Healthcare -
Biotechnology - NASDAQ - US
$ 9.08
4.73 %
$ 531 M
Market Cap
-3.27
P/E
CGEM - STOCK-BASED COMPENSATION
Stock-based Compensation CGEM - Cullinan Oncology, Inc.
30.4 M
LAST VALUE
11.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR